Lobbying client

AQUESTIVE THERAPEUTICS

pharmaceutical company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
38
Filed by
3
Reported in-house
—
Reported by firms
$780,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2019 to 2026

Filings

38 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination
1st Quarter 2023
RUBICON ADVISORS, LLC — reported
4th Quarter - Report
4th Quarter 2023
RUBICON ADVISORS, LLC $45,000 reported
3rd Quarter - Report
3rd Quarter 2023
RUBICON ADVISORS, LLC $45,000 reported
2nd Quarter - Report
2nd Quarter 2023
RUBICON ADVISORS, LLC $45,000 reported
2nd Quarter - Termination (No Activity)
2nd Quarter 2023
STEPTOE LLP — reported
1st Quarter - Report
1st Quarter 2023
RUBICON ADVISORS, LLC $45,000 reported
1st Quarter - Report (No Activity)
1st Quarter 2023
STEPTOE LLP — reported
4th Quarter - Report (No Activity)
4th Quarter 2022
STEPTOE LLP — reported
4th Quarter - Report
4th Quarter 2022
RUBICON ADVISORS, LLC $45,000 reported
3rd Quarter - Report (No Activity)
3rd Quarter 2022
STEPTOE LLP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
RUBICON ADVISORS, LLC 9 $360,000
BRACEWELL LLP 5 $290,000
STEPTOE LLP 19 $130,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 14
Pharmacy PHA 13
Consumer Issues/Safety/Products CSP 6

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 1262 119th 3
S. 932 119th 3
H.R. 1629 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.